FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023
FOCUS Investment Banking Named #1 Lower Middle Market M&A ...
ENT & Allergy Practices Attract Private Equity
ENT & Allergy Practices Attract Private Equity Armed ...
East Coast Retina, PA Case Study
East Coast Retina, PA Case Study East Coast ...
FOCUS Investment Banking Represents East Coast Retina, PA in its Sale to Retina Consultants of America
FOCUS Investment Banking Represents East Coast Retina, PA in ...
Private Equity Interest in Orthopedics Grows
Compared to other medical fields like dentistry and dermatology, private equity involvement in orthopedic practices has been relatively small. But that’s been changing over the past few years and is likely to continue to grow moving forward.
Private Equity’s Increasing Consolidation of Oncology Practices
On April 23 a group led by private equity firm TPG agreed to acquire OneOncology, the nation’s largest independent community oncology network, in a deal valued at $2.1 billion. AmerisourceBergen, the big drug wholesaler, is buying a minority stake in the firm; OneOncology’s affiliated practices, physicians, and management team will also retain a minority interest.
M&A Ophthalmology Deals Continue Into 2023 with Small And Mid-Size Transactions
The first quarter of 2023 delivered ten reported ophthalmology practice acquisitions, which aligns with seasonal acquisition trends (Q1 of 2022 reported eleven deals).
OPHTHALMOLOGY: A Great Time for Sellers to Do a Deal
The ophthalmology sector continues to be a robust market entering Q2 2023. There are more than 25 core private equity platforms within ophthalmology, plus smaller regional PE-backed groups. Read more here.
EBITDA Valuations Explained
Do you know what two factors drive the most value in your practice sale? How are practices even valued by private equity investors? Hear it directly from one of our seasoned investment bankers.
The Winning Team
A solid team is the key to a successful transaction.